MICHAEL WOUDENBERG - 19 Dec 2025 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Chief Operating Officer
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg
Issuer symbol
INM
Transactions as of
19 Dec 2025
Net transactions value
$0
Form type
4
Filing time
19 Dec 2025, 11:41:09 UTC
Previous filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WOUDENBERG MICHAEL Chief Operating Officer C/O INMED PHARMACEUTICALS INC., 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA /s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg 19 Dec 2025 0001817884

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +18,000 +242% $0.000000 25,445 19 Dec 2025 Common shares 18,000 $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)